In the last 12 months, insiders at Anebulo Pharmaceuticals, Inc. ($ANEB) filed 39 transactions with the SEC: 1 open-market purchases totaling $10,000,000 and 0 sales totaling $0. Net insider sentiment: net buying.
Anebulo Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- English Aron R. (Director) — 8 transactions totaling $10,000,000
- Cundy Kenneth C (Chief Scientific Officer) — 3 transactions totaling $0
- Aryeh Jason (Director) — 4 transactions totaling $0
- Kupchyk Areta (Director) — 4 transactions totaling $0
- Calloway Nathaniel (Director) — 4 transactions totaling $0
View all SEC Filings for Anebulo Pharmaceuticals, Inc. (ANEB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 4, 2025 | Lawler Joseph F. | Director | A | Stock Option (right to buy) | 13236 | $0.00 | 13,236.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Lawler Joseph F. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | SHAH BIMAL R. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | SHAH BIMAL R. | Director | A | Stock Option (right to buy) | 6618 | $0.00 | 6,618.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Cundy Kenneth C | Chief Scientific Officer | A | Stock Option (right to buy) | 115037 | $0.00 | 115,037.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Aryeh Jason | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Aryeh Jason | Director | A | Stock Option (right to buy) | 4964 | $0.00 | 4,964.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Cunningham, Richard Anthony | Chief Executive Officer | A | Stock Option (right to buy) | 316352 | $0.00 | 316,352.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Lin Kenneth | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Lin Kenneth | Director | A | Stock Option (right to buy) | 4964 | $0.00 | 4,964.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | English Aron R. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | English Aron R. | Director | A | Stock Option (right to buy) | 2647 | $0.00 | 2,647.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 3309 | $0.00 | 3,309.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Kupchyk Areta | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Kupchyk Areta | Director | A | Stock Option (right to buy) | 2647 | $0.00 | 2,647.0000 | 0 | 9999.99% | 0.00% |
| Dec. 23, 2024 | English Aron R. | Director | P | Common Stock | 10101010 | $0.99 | 20,121,828.0000 | 0 | 100.80% | 0.00% |
| Dec. 9, 2024 | Cunningham, Richard Anthony | Chief Executive Officer | A | Stock Option (right to buy) | 254433 | $0.00 | 254,433.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Lin Kenneth | Director | A | Stock Option (right to buy) | 2482 | $0.00 | 2,482.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Lin Kenneth | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Calloway Nathaniel | Director | A | Stock Option (right to buy) | 1655 | $0.00 | 1,655.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Kupchyk Areta | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Kupchyk Areta | Director | A | Stock Option (right to buy) | 1324 | $0.00 | 1,324.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Lawler Joseph F. | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Lawler Joseph F. | Director | A | Stock Option (right to buy) | 6618 | $0.00 | 6,618.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | English Aron R. | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | English Aron R. | Director | A | Stock Option (right to buy) | 1324 | $0.00 | 1,324.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | SHAH BIMAL R. | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | SHAH BIMAL R. | Director | A | Stock Option (right to buy) | 3309 | $0.00 | 3,309.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Aryeh Jason | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Aryeh Jason | Director | A | Stock Option (right to buy) | 2482 | $0.00 | 2,482.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Cundy Kenneth C | Chief Scientific Officer | A | Stock Option (right to buy) | 72613 | $0.00 | 72,613.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Cundy Kenneth C | Chief Scientific Officer | A | Stock Option (right to buy) | 72613 | $0.00 | 72,613.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2023 | English Aron R. | Director | G | Common Stock | 300000 | $0.00 | 10,020,818.0000 | 0 | 2.91% | 0.00% |
| Dec. 18, 2023 | English Aron R. | Director | G | Common Stock | 300000 | $0.00 | 10,020,818.0000 | 0 | 3.09% | 0.00% |
| Nov. 13, 2023 | English Aron R. | Director | A | Common Stock | 300000 | $0.00 | 10,320,818.0000 | 0 | 2.99% | 0.00% |
| Oct. 6, 2023 | Cunningham, Richard Anthony | Chief Executive Officer | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 6, 2023 | SHAH BIMAL R. | Director | A | Stock Option (right to buy) | 26097 | $0.00 | 26,097.0000 | 0 | 9999.99% | 0.00% |